Gentium S.p.a (NASDAQ:GENT) will report earnings before markets open on Tuesday, August 13th. Gentium Spa is a biopharmaceutical company focused on the discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments.
Here is your Cheat Sheet to Gentium S.p.a Earnings:
Earnings Expectations: Analysts expect earnings of $0.04 per share on revenues of $12.08 million. Currently, the company’s P/E ratio stands at 70.05.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.2 to a profit $0.1. For the current year, the average estimate is a profit of $0.32, which is worse than the estimate ninety days ago.
Here’s how Gentium S.p.a has been performing on an annual basis:
|Revenue ($) in millions||11||14||33||30||36|
|Diluted EPS ($)||-1.95||-0.41||0.38||0.23||0.06|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||10.96||9.42||9.59||10.51|
|Diluted EPS ($)||0.06||0.02||0.05||0.06|
Gentium S.p.a has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)